3645 results for «706»
3645 results
Left main bifurcations: latest clinical data applied to practical cases
18 May 2022 – From EUROPCR 2022
Why should the stenting strategy be adapted to side branch lesion length? How to use intracoronary imaging to improve outcomes? This session will address those questions and show you through a series of cases, examples of left main PCI from the European Bifurcation Club main trial...
TAVI for aortic regurgitation - Addressing an unmet need with the JenaValve Trilogy heart valve system
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to learn all about the unmet need in treating AR, to discover the performance of the Trilogy System (a new TAVI device for the treatment of AR), as well as to explore the future of TAVI for AR.
TricValve - Addressing the unmet need for patients with right heart failure and functional tricuspid regurgitation - Real-life clinical outcomes
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to learn all about the latest treatment option for patients with severe TR, to discover the supporting clinical evidence of TricValve, and to understand how the TricValve Transcatheter Bicaval Valves System can improve patient's quality of life.
Your most challenging TAVI cases - Achieving precision and control with Evolut platform
18 May 2022 – From EuroPCR 2022
How to deal with challenging anatomies? Find answers in this EuroPCR 2022 session with case studies to explore and learn how to achieve optimal patient outcomes with Evolut platform, uncover practical tips and techniques to achieve implant precision and control, and become familiar with technical considerations and procedural execution...
FAVOR III China: Angiographic quantitative flow ratio-guided coronary intervention - a multicentre, randomised, sham-controlled trial
04 Nov 2021
Nicola Ryan provides her take on this investigator initiated, multicentre, randomised, blinded, sham controlled trial compares clinical outcomes of QFR versus angiography guided strategies for the treatment of non-critical lesions in patients with stable or unstable angina or MI at least 72 hours prior to screening....
Author
